From March 11, 2024 to March 31, 2024, the company has repurchased 611,267 shares, representing 0.15% for CNY 17.01 million. With this, the company has completed the repurchase of 611,267 shares, representing 0.15% for CNY 17.01 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.45 CNY | +1.14% | -0.84% | -12.49% |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Tech Sector Galvanizes Asian Stock Markets | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.49% | 1.63B | |
-2.25% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.